Adjunctive treatment strategies for high-risk ocular melanoma

Sapna P. Patel; Dan Gombos

doi:10.2217/FMEB2013.13.35

Adjunctive treatment strategies for high-risk ocular melanoma

Sapna P. Patel, Dan Gombos

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Currently, the use of adjuvant therapy for uveal melanoma is a wide-open question. To begin to answer the question, we need to define our high-risk population perhaps more uniformly using only genetic testing, utilize appropriate targets and implement thoughtful trial design.

Original language	English (US)
Title of host publication	Ocular Melanoma: Advances in Diagnostic and Therapeutic Strategies
Publisher	Future Medicine Ltd.
Pages	160-167
Number of pages	8
ISBN (Print)	9781780844268, 9781780844282
DOIs	https://doi.org/10.2217/FMEB2013.13.35
State	Published - Jul 1 2014

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.2217/FMEB2013.13.35

Cite this

@inbook{93bd7b3333b54da5adef628d036f461c,

title = "Adjunctive treatment strategies for high-risk ocular melanoma",

abstract = "Currently, the use of adjuvant therapy for uveal melanoma is a wide-open question. To begin to answer the question, we need to define our high-risk population perhaps more uniformly using only genetic testing, utilize appropriate targets and implement thoughtful trial design.",

author = "Patel, {Sapna P.} and Dan Gombos",

year = "2014",

month = jul,

day = "1",

doi = "10.2217/FMEB2013.13.35",

language = "English (US)",

isbn = "9781780844268",

pages = "160--167",

booktitle = "Ocular Melanoma: Advances in Diagnostic and Therapeutic Strategies",

publisher = "Future Medicine Ltd.",

address = "United Kingdom",

}

TY - CHAP

T1 - Adjunctive treatment strategies for high-risk ocular melanoma

AU - Patel, Sapna P.

AU - Gombos, Dan

PY - 2014/7/1

Y1 - 2014/7/1

N2 - Currently, the use of adjuvant therapy for uveal melanoma is a wide-open question. To begin to answer the question, we need to define our high-risk population perhaps more uniformly using only genetic testing, utilize appropriate targets and implement thoughtful trial design.

AB - Currently, the use of adjuvant therapy for uveal melanoma is a wide-open question. To begin to answer the question, we need to define our high-risk population perhaps more uniformly using only genetic testing, utilize appropriate targets and implement thoughtful trial design.

UR - http://www.scopus.com/inward/record.url?scp=84956781141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956781141&partnerID=8YFLogxK

U2 - 10.2217/FMEB2013.13.35

DO - 10.2217/FMEB2013.13.35

M3 - Chapter

AN - SCOPUS:84956781141

SN - 9781780844268

SN - 9781780844282

SP - 160

EP - 167

BT - Ocular Melanoma: Advances in Diagnostic and Therapeutic Strategies

PB - Future Medicine Ltd.

ER -

Adjunctive treatment strategies for high-risk ocular melanoma

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this